期刊文献+

脓毒症大鼠血清miR-9的表达及其意义 被引量:1

Detection of miR- 9 in serum of septic rats and its significance
暂未订购
导出
摘要 目的探讨检测脓毒症大鼠血清中miR-9的表达及其意义。方法将54只大鼠分为假手术组24只、脓毒症组24只和正常对照组6只。建立盲肠结扎穿孔脓毒症动物模型。检测各组大鼠血清中白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)和C反应蛋白(CRP)浓度水平,评估脓毒症炎症反应情况;实时荧光定量RT-PCR法检测大鼠血清中miR-9的表达情况;皮尔森相关分析评估血清miR-9的表达与IL-6、TNF-α和CRP之间的关系。结果脓毒症大鼠血清miR-9的表达水平较正常对照组和假手术组显著升高(P均<0.01),术后2 h血清miR-9表达即迅速上升达到一个较高水平。皮尔森相关分析结果也显示血清miR-9的表达与IL-6、TNF-α和CRP呈正相关(P均<0.01)。结论脓毒症大鼠血清miR-9表达显著增高,其水平反映机体炎症反应状态,可以作为脓毒症早期诊断及预后的指标。 Objective It is to investigates the expression of miR- 9 in serum of septic rats,as well as its significance.Methods 54 rats were divided into sham group( n = 24),sepsis group( n = 24) and normal control group( n = 6). Animal models of sepsis were established by cecal ligation and puncture. The serum levels of IL- 6,TNF- α and CRP were measured in every group to evaluate the severity of sepsis. The expression level of serum miR- 9 was determined by reverse transcription polymerase chain reaction( RT- PCR). Pearson's correlation analysis was used to evaluate if the expression of serum miR-9 had correlation with IL- 6、TNF- α and CRP. Results Expression level of miR- 9 in rats' serum in sepsis group was significantly higher than that in normal control group and sham group( P〈0. 01),which was very low under normal condition,was significantly increased at 2 h after CLP. Pearson's correlation analysis also showed that the level of serum miR- 9 had positive correlation with IL- 6、TNF- α and CRP( P〈0. 01). Conclusion The significantly up-regulated expression levels of serum miR- 9 in septic rats reflected the situation of inflammatory response,and may be used as a diagnostic and prognostic marker in sepsis.
作者 杨炯 李新宇
出处 《现代中西医结合杂志》 CAS 2015年第4期364-366,369,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 脓毒症 血清miR-9 白细胞介素-6 肿瘤坏死因子Α C反应蛋白 sepsis serum miR-9 IL-6 TNF-α CRP
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1007

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部